vimarsana.com

Latest Breaking News On - Hemmo pharmaceuticals pvt ltd - Page 1 : vimarsana.com

Piramal Pharma Limited Announces Consolidated Results for Q4 and FY2023

/PRNewswire/ Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the fourth quarter (Q4) and full year FY23.

Hong kongUnited kingdomAndhra pradeshNew yorkUnited statesCity ofYapan bioNandini piramalPiramal pharma solutionsCarlyle groupHemmo pharmaceuticals pvt ltdAbbvie incPiramal pharmaPiramal enterprises ltdConvergence chemical pvt ltdManufacturing organization

Piramal Pharma Ltd: Piramal Pharma Limited Announces Consolidated Results for Q4 and FY2023

MUMBAI, India, May 24, 2023 /PRNewswire/ Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the fourth quarter (Q4) and full year FY23 ended

New yorkUnited statesUnited kingdomCity ofAndhra pradeshHong kongNandini piramalYapan bioGewinn nurHemmo pharmaceuticals pvt ltdPiramal pharma limitedPiramal enterprises ltdConvergence chemical pvt ltdCarlyle groupManufacturing organizationPrnewswire piramal pharma limited

Piramal Pharma Limited Announces Consolidated Results for Q4 and FY2023

/PRNewswire/ Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the fourth quarter (Q4) and full year FY23.

United kingdomCity ofUnited statesHong kongAndhra pradeshNew yorkYapan bioNandini piramalHemmo pharmaceuticals pvt ltdPiramal pharma solutionsCarlyle groupAbbvie incPiramal pharmaPiramal enterprises ltdConvergence chemical pvt ltdManufacturing organization

Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023

/PRNewswire/ Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the third quarter (Q3) and nine month (9M).

New yorkUnited statesHong kongUnited kingdomCity ofNandini piramalContract developmentHemmo pharmaceuticals pvt ltdPiramal pharma ltdPrnewswire piramal pharma limitedCarlyle groupManufacturing organizationPiramal pharma solutionsConvergence chemical pvt ltdPiramal pharmaPiramal pharma limited

Piramal Pharma Ltd: Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023

MUMBAI, India, Feb. 8, 2023 /PRNewswire/ Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the third quarter (Q3) and nine month (9M) ended

New yorkUnited statesHong kongUnited kingdomCity ofNandini piramalSchwierige zeitenContract developmentHemmo pharmaceuticals pvt ltdPiramal pharma ltdPrnewswire piramal pharma limitedCarlyle groupManufacturing organizationPiramal pharma solutionsConvergence chemical pvt ltdPiramal pharma

vimarsana © 2020. All Rights Reserved.